These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1963686)
1. New antibiotics. Davies A Practitioner; 1990 Dec; 234(1497):1046, 1048, 1051. PubMed ID: 1963686 [No Abstract] [Full Text] [Related]
2. [The current status of the science of antibiotics and the outlook for its development]. Navashin SM Ter Arkh; 1992; 64(8):4-8. PubMed ID: 1440394 [No Abstract] [Full Text] [Related]
4. [Bacterial internalization and intracellular activity of quinolones and macrolides]. Bellussi L; De Benedetto M; Lauriello M; Passali GC; Passali D Acta Otorhinolaryngol Ital; 2007 Apr; 27(2 Suppl 87):1-11. PubMed ID: 17702375 [No Abstract] [Full Text] [Related]
5. [How can we protect against broad-band pathogens? The situation with quinolone resistance]. Kresken M; Hafner D Pharm Unserer Zeit; 2001; 30(5):436-45. PubMed ID: 11575181 [No Abstract] [Full Text] [Related]
6. [Genetic and biochemical basis of microbial resistance to antibiotics]. Popović M; Delić V Lijec Vjesn; 1990; 112(7-8):250-7. PubMed ID: 2292900 [TBL] [Abstract][Full Text] [Related]
7. [A comment on the contribution by H. Rosin: "Beta-lactam antibiotics"]. Cullmann W; Opferkuch W Internist (Berl); 1989 Sep; 30(9):628-9. PubMed ID: 2807787 [No Abstract] [Full Text] [Related]
9. Infections in intensive care patients: use of new B-lactams. Neu HC Bull N Y Acad Med; 1984 Sep; 60(7):732-47. PubMed ID: 6386084 [No Abstract] [Full Text] [Related]
11. [Resistance of gram-negative bacteria to beta-lactams, aminoglycosides and quinolones]. Schumacher H; Thomsen VF Ugeskr Laeger; 1994 Oct; 156(42):6185-90. PubMed ID: 7998354 [TBL] [Abstract][Full Text] [Related]
12. [Antibiotics, developments and orientation]. de Marie S; Verbrugh HA Ned Tijdschr Geneeskd; 1992 Apr; 136(14):673-8. PubMed ID: 1560853 [No Abstract] [Full Text] [Related]
13. [Bacterial resistance to beta-lactam antibiotics]. Roy C Med Clin (Barc); 1983 Sep; 81(7):299-301. PubMed ID: 6606092 [No Abstract] [Full Text] [Related]
14. Global antibiotic resistance and its impact on the dental community. Pallasch TJ J Calif Dent Assoc; 2000 Mar; 28(3):215-33. PubMed ID: 11326536 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. García-Rey C; Martín-Herrero JE; Baquero F Clin Microbiol Infect; 2006 May; 12 Suppl 3():55-66. PubMed ID: 16669929 [TBL] [Abstract][Full Text] [Related]
16. [Results of a control program on the use of antibiotics]. Wolff M Rev Med Chil; 1984 Nov; 112(11):1096-1103. PubMed ID: 6537004 [No Abstract] [Full Text] [Related]
17. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. Vergis EN; Yu VL Semin Respir Infect; 1997 Dec; 12(4):322-8. PubMed ID: 9436959 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000. Phillips OA; Matowe WC Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651 [TBL] [Abstract][Full Text] [Related]
20. [Possible development of resistance to quinolones. Its significance for general practice]. Mohr CP Fortschr Med; 1988 Mar; 106(9):181-4. PubMed ID: 3286434 [No Abstract] [Full Text] [Related] [Next] [New Search]